Chemotherapy in Treating Patients With Early-Stage Bladder Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

September 1, 1998

Primary Completion Date

November 30, 2002

Study Completion Date

May 1, 2009

Conditions
Bladder Cancer
Interventions
DRUG

valrubicin

Trial Locations (10)

19096

CCOP - MainLine Health, Wynnewood

19111

Fox Chase Cancer Center, Philadelphia

53226

Medical College of Wisconsin, Milwaukee

53295

Veterans Affairs Medical Center - Milwaukee (Zablocki), Milwaukee

53705

Veterans Affairs Medical Center - Madison, Madison

54301

CCOP - Green Bay, Green Bay

61801

CCOP - Carle Cancer Center, Urbana

33612-9497

H. Lee Moffitt Cancer Center and Research Institute, Tampa

07018-1095

Veterans Affairs Medical Center - East Orange, East Orange

53792-6164

University of Wisconsin Comprehensive Cancer Center, Madison

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Eastern Cooperative Oncology Group

NETWORK

NCT00003129 - Chemotherapy in Treating Patients With Early-Stage Bladder Cancer | Biotech Hunter | Biotech Hunter